Pyoderma gangrenosum treated with hyperbaric oxygen therapy. | Canada Hyperbarics Skip to main content
Clinical Study International journal of dermatology 1992

Pyoderma gangrenosum treated with hyperbaric oxygen therapy.

Wasserteil V, Bruce S, Sessoms SL, Guntupalli KK — International journal of dermatology, 1992

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the successful treatment of pyoderma gangrenosum with hyperbaric oxygen therapy in a single patient.

What They Found

In one patient with severe rheumatoid arthritis and diabetes mellitus, hyperbaric oxygen therapy promoted the healing of pyoderma gangrenosum. This therapy also allowed for a reduction in the patient's systemic corticosteroid dosage.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.

Study Limitations

The primary limitation of this study is its design as a single case report, which limits the generalizability of the findings to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 1428456
Year Published 1992
Journal International journal of dermatology
MeSH Terms Arthritis, Rheumatoid; Diabetes Complications; Female; Humans; Hyperbaric Oxygenation; Middle Aged; Pyoderma Gangrenosum

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology